Gene–environment interactions for complex traits: definitions, methodological requirements and challenges
暂无分享,去创建一个
Jenny Chang-Claude | Astrid Dempfle | André Scherag | Helmut Schäfer | Rebecca Hein | J. Chang-Claude | R. Hein | A. Scherag | L. Beckmann | A. Dempfle | Lars Beckmann | H. Schäfer
[1] S. Ebrahim,et al. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? , 2003, International journal of epidemiology.
[2] N E Day,et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection , 2002, Public Health Nutrition.
[3] M. Caldwell,et al. A prospective, randomized pilot trial of model-based warfarin dose initiation using CYP2C9 genotype and clinical data. , 2005, Clinical medicine & research.
[4] J. Rees,et al. The genetics of sun sensitivity in humans. , 2004, American journal of human genetics.
[5] M. Levin,et al. Genetic susceptibility to infectious diseases. , 2003, The Pediatric Infectious Disease Journal.
[6] M. Plebanski,et al. Malaria parasite interactions with the human host. , 2004, Journal of postgraduate medicine.
[7] D. Altshuler,et al. The multiethnic cohort study: exploring genes, lifestyle and cancer risk , 2004, Nature Reviews Cancer.
[8] J. Beckmann,et al. Trick or treat: The effect of placebo on the power of pharmacogenetic association studies , 2005, Human Genomics.
[9] Testing linkage and Gene × Environment interaction: Comparison of different affected sib‐pair methods , 2003, Genetic epidemiology.
[10] M J Khoury,et al. Evolving methods in genetic epidemiology. III. Gene-environment interaction in epidemiologic research. , 1997, Epidemiologic reviews.
[11] W James Gauderman,et al. Sample size requirements for matched case‐control studies of gene–environment interaction , 2002, Statistics in medicine.
[12] J. Blackwell,et al. Genetics and genomics in infectious disease susceptibility. , 2001, Trends in molecular medicine.
[13] D. Hunter. Gene–environment interactions in human diseases , 2005, Nature Reviews Genetics.
[14] J M Robins,et al. Differential misclassification and the assessment of gene-environment interactions in case-control studies. , 1998, American journal of epidemiology.
[15] Artemis P. Simopoulos,et al. Nutrigenetics and nutrigenomics , 2004 .
[16] Paolo Vineis,et al. A self-fulfilling prophecy: are we underestimating the role of the environment in gene-environment interaction research? , 2004, International journal of epidemiology.
[17] P. Brown,et al. Iatrogenic Creutzfeldt‐Jakob disease , 1994, Neurology.
[18] A. N. Pettitt,et al. One Degree of Freedom for Nonadditivity: Applications with Generalized Linear Models and Link Functions , 1989 .
[19] D J Schaid,et al. Potential misinterpretation of the case-only study to assess gene-environment interaction. , 1999, American journal of epidemiology.
[20] D. Spiegelman,et al. Power and sample size calculations for case-control studies of gene-environment interactions with a polytomous exposure variable. , 1997, American journal of epidemiology.
[21] C R Weinberg,et al. Designing and analysing case-control studies to exploit independence of genotype and exposure. , 1997, Statistics in medicine.
[22] G. Rose. Sick individuals and sick populations. , 2001, International journal of epidemiology.
[23] L. C. Stene. Study of genes and environmental factors in complex diseases , 2002, The Lancet.
[24] J. Ioannidis,et al. Replication validity of genetic association studies , 2001, Nature Genetics.
[25] Howard L McLeod,et al. Prospective dosing of warfarin based on cytochrome P-450 2C9 genotype , 2005, Thrombosis and Haemostasis.
[26] D. Thomas,et al. The role of interacting determinants in the localization of genes. , 2001, Advances in genetics.
[27] J. Witte,et al. Family-based association studies. , 1999, Journal of the National Cancer Institute. Monographs.
[28] Peter Kraft,et al. Exploiting Gene-Environment Interaction to Detect Genetic Associations , 2007, Human Heredity.
[29] J H Lubin,et al. Power and sample size calculations in case-control studies of gene-environment interactions: comments on different approaches. , 1999, American journal of epidemiology.
[30] Allen D. Roses,et al. Pharmacogenetics and drug development: the path to safer and more effective drugs , 2004, Nature Reviews Genetics.
[31] R. Judson. Using Multiple Drug Exposure Levels to Optimize Power in Pharmacogenetic Trials , 2003, Journal of clinical pharmacology.
[32] D. Rao,et al. An epidemiologic approach to gene‐environment interaction , 1990, Genetic epidemiology.
[33] David Clayton,et al. Epidemiological methods for studying genes and environmental factors in complex diseases , 2001, The Lancet.
[34] D J Schaid,et al. Case‐parents design for gene‐environment interaction , 1999, Genetic epidemiology.
[35] L. Abel,et al. Genetic epidemiology of infectious diseases in humans: design of population-based studies. , 1998, Emerging infectious diseases.
[36] David B. Goldstein,et al. Pharmacogenetics goes genomic , 2003, Nature Reviews Genetics.
[37] Raymond J Carroll,et al. Exploiting gene‐environment independence in family‐based case‐control studies: Increased power for detecting associations, interactions and joint effects , 2005, Genetic epidemiology.
[38] R C Elston,et al. The study of candidate genes in drug trials: sample size considerations. , 1999, Statistics in medicine.
[39] Sample Size Calculations for Main Effects and Interactions in Case–control Studies using Stata's nchi2 and npnchi2 Functions , 2003 .
[40] Walter C Willett,et al. Balancing Life-Style and Genomics Research for Disease Prevention , 2002, Science.
[41] Stephen G Ryan. Regression to the truth: replication of association in pharmacogenetic studies. , 2003, Pharmacogenomics.
[42] Andrew G Rundle,et al. Further development of the case-only design for assessing gene-environment interaction: evaluation of and adjustment for bias. , 2004, International journal of epidemiology.
[43] W D Flanders,et al. Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: case-control studies with no controls! , 1996, American journal of epidemiology.
[44] Nigel Stallard,et al. Statistical design and analysis of pharmacogenetic trials , 2005, Statistics in medicine.
[45] H. Cordell. Epistasis: what it means, what it doesn't mean, and statistical methods to detect it in humans. , 2002, Human molecular genetics.
[46] W. Thompson,et al. Effect modification and the limits of biological inference from epidemiologic data. , 1991, Journal of clinical epidemiology.
[47] Jenny Chang-Claude,et al. Sample size requirements for indirect association studies of gene–environment interactions (G × E) , 2008, Genetic epidemiology.
[48] J J Goedert,et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. , 1997, Science.
[49] M. Fallin,et al. Genetic dissection methods: designs used for tests of gene-environment interaction. , 2004, Current opinion in genetics & development.
[50] E. Begg,et al. Pharmacogenetic testing for drug metabolizing enzymes: is it happening in practice? , 2005, Pharmacogenetics and genomics.
[51] R C Elston,et al. Testing drug response in the presence of genetic information: sampling issues for clinical trials. , 2000, Pharmacogenetics.
[52] N E Day,et al. Sample size determination for studies of gene-environment interaction. , 2001, International journal of epidemiology.
[53] J. Witte,et al. Asymptotic bias and efficiency in case-control studies of candidate genes and gene-environment interactions: basic family designs. , 1999, American journal of epidemiology.
[54] J. Wittes,et al. Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. , 1991, JAMA.
[55] P. Brennan,et al. Gene-environment interaction and aetiology of cancer: what does it mean and how can we measure it? , 2002, Carcinogenesis.